RISPERDAL CONSTA og associerede navne (se Bilag I) 25 mg pulver til depotinjektionsvæske, suspension til intramuskulær injektion
Hypercalcemia, postulated to contribute to an increased incidence of adrenal medullary tumours in RISPERDAL CONSTA-treated rats, was observed in both dose groups.